T cells require TRAIL for optimal graft-versus-tumor activity

Area of Science:

• Immunology
• Cancer Biology
• Transplantation Science

Background:

• Tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) is crucial for immune surveillance and tumor cell apoptosis.
• The graft-versus-tumor (GVT) effect in allogeneic hematopoietic-cell transplantation relies on donor T cell reactivity against malignant cells.
• Existing T cell-mediated cytotoxicity pathways include Fas-Fas ligand and perforin-granzyme, but other mechanisms may exist.

Purpose of the Study:

• To investigate the role of TRAIL in donor T cell-mediated GVT activity during allogeneic hematopoietic-cell transplantation.
• To compare the GVT effect and graft-versus-host disease (GVHD) mediated by TRAIL-deficient and wild-type T cells in mouse models.

Main Methods:

• Utilized clinically relevant mouse bone-marrow transplantation models.
• Compared donor T cells from TRAIL-deficient and wild-type mice.
• Assessed T cell proliferation, cytokine response, GVT activity, and GVHD.

Main Results:

• Alloreactive T cells can express TRAIL.
• Absence of TRAIL did not affect T cell proliferation or cytokine response to alloantigens.
• TRAIL-deficient T cells exhibited significantly lower GVT activity compared to TRAIL-expressing T cells.
• No significant differences in graft-versus-host disease were observed between groups.

Conclusions:

• TRAIL plays a role in mediating GVT activity in T cells during allogeneic hematopoietic-cell transplantation.
• TRAIL-mediated pathways contribute to GVT effects independently of Fas and perforin pathways.
• Strategies to enhance TRAIL could improve GVT activity and reduce cancer relapse rates post-transplantation without worsening GVHD.